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Summary: Chronic exposure to lead is associated with adverse effects on renal function in laboratory 
animals and man. There is controversy concerning the direction of change of renal function parameters 
following chronic lead intoxication. The renal effects of low-dose lead exposure, as opposed to acute 
and pharmacological doses, require further scrutiny. In order to determine the effect of prolonged low-
dose lead exposure, male Sprague Dawley rats (initial weight, 150.5±17.4g; final weight, 300.5±17.4g; 
n=10) administered lead acetate (100 p.p.m.) in drinking water over a period of 3 months, were 
investigated for renal function parameters.  Treated rats had elevated blood pressures (114.4±4.2 vs. 
95.7±3.5 mmHg; P<0.01). There was no significant difference in renal blood flow (3.99±0.28 vs. 
4.19±0.63 ml/min; P=NS). GFR was comparable in the two groups (0.77±0.05 vs. 0.88±0.06 ml/min; 
P=NS). No significant difference in serum creatinine was observed (57.8±7.5 vs. 49.0±2.7 μmol/l; 
P=NS). Renal histology showed minimal interstitial changes in the experimental group. Interestingly, 
significant sodium (P<0.01); potassium (P<0.05) and chloride (P<0.05) retention were observed in the 
lead treated rats. Elevation of blood pressure occurred at a stage when low-level lead exposure did not 
alter renal function parameters appreciably.  These results suggest that hypertension may be a 
forerunner of significant renal damage following chronic exposure to low-levels of lead and further 
underscore fluid and electrolyte retention as a significant mechanism responsible for elevated blood 
pressure in the chronic stages of lead exposure. 
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Introduction 
Environmental lead poisoning is an 
increasing health burden and chronic exposure 
to high levels of lead leads to adverse effects 
on renal function and the hematopoietic system 
in both animals and humans (Hotz et al., 
1996). Lead-induced renal damage also occurs 
in the absence of acute intoxication so that 
occult lead nephropathy may not be recognized 
as such (Restek-Samarzija et al., 1997). Delay 
in the onset of adverse effect of lead poisoning 
on kidney function and blood pressure 
elevation are known to occur in previous lead 
workers (Restek-Samarzija et al., 1996, 
Restek-Samarzija & Momcilovic, 1992). 
Chronic accumulation of lead in the body 
eventually leads to impairment in renal 
function (Restek-Samarzija et al., 1996). 
 There is no uniformity on the direction of 
change of renal function parameters in chronic 
lead poisoning. Some studies reported a 
stimulatory effect of lead on renal hypertrophy 
and glomerular filtration rate (GFR) during 
lead exposure (Khalil-Manesh et al., 1994) 
while others reported a significantly reduced 
glomerular filtration rate, adjusted for age 
(Restek-Samarzija & Momcilovic, 1992).  
In animal studies, acute low-dose lead-
treatment caused no significant pathological 
changes in rats (Khalil-Manesh et al., 1992). 
The disparity in the onset of renal function 
abnormalities reported in laboratory animals 
appear to be related to the duration and dose of 
lead administration. Thus Khalil-Manesh et al., 
(1992) found no functional or pathological 
changes in rats when lead exposure was 
discontinued after 1 month. Exposure beyond 6 
months led to severe tubulointerstitial disease 
which resulted in significantly decreased GFR 
with attendant increase in serum creatinine and 
urea nitrogen (Khalil-Manesh et al., 1992).  
The hypothesis advanced by some 
workers suggesting that a high dose of lead 
stimulates renal cortical hypertrophy and 
increases GFR in the early stages which later 
results in a fall in GFR as a result of 
tubulointerstitial changes (Khalil-Manesh et al 
1992) requires further clarification. Most 




studies on the effect of lead on renal function 
parameters investigated high doses of lead 
(Restek-Samarzija et al., 1997; Khalil-Manesh 
et al., 1994; Restek-Samarzija et al., 1992; 
Khalil-Manesh et al., 1992; Tejani et al., 1986; 
Aviv et al., 1980). The effect of exposure to 
low levels of lead over a prolonged period of 
time on renal function as opposed to acute and 
pharmacological exposures requires closer 
scrutiny. 
Renal function parameters were therefore 
investigated in male Sprague Dawley (SD) rats 
exposed to low levels (100 p.p.m.) of lead 
acetate in drinking water over a period of 3 
months in order to determine the effect of 
prolonged low-level lead exposure on renal 
function parameters. 
 
Materials and Methods  
Animal Preparation 
Male SD rats which were used in the 
study, weighed 150.5±17.4 g (n=10) at the 
beginning of the experiment. The room in 
which the rats were kept was maintained at a 
light / dark cycle of 12 hours, a temperature of 
28 oC to 32 oC and a relative humidity of about 
60 %.  The rats were allowed free access to 
normal rat chow. Treated rats received 
drinking water containing 100 parts per million 
(p.p.m.) of lead acetate provided in lick-proof 
water bottles for 3 months (Ding et al., 1998) 
while control rats received tap water. This 
level of lead exposure is known to cause 
significant elevation of serum lead levels in the 
rat (Carmignani et al, 2000).   The animals 
received standard institutional care throughout 
the period of observation. 
 
Clearance studies 
At the end of the observation period (3 
months), rats were subjected to standard 
clearance experiments in order to establish 
whether or not there were significant changes 
in renal function parameters in the treated rats 
compared to controls. The animals were 
weighed and anaesthetized with a mixture of 
1% (w/v) alpha-chloralose and 25% (w/v) 
urethane in normal saline at a dose of 5ml/kg 
intraperitonially.  It has previously been 
reported that this preparation does not alter 
resting blood pressure, heart rate and 
cardiovascular responses for at least 3 hours 
after anesthesia (Adigun, 1986). A 
tracheostomy was performed to guarantee 
spontaneous breathing. A polyethylene 
catheter (PP50) was introduced into the left 
carotid artery for continuous blood pressure 
recording. The arterial catheter was connected 
to a blood pressure transducer (P23D Statham, 
Hato Rey, Puerto Rico) and blood pressure 
was recorded on a Grass Polygraph Model 7D 
(Grass Instruments Co., Quincy Mass. U.S.A.). 
Through the cannulated right femoral vein 
(PP50 polyethylene catheter), the rats received 
sterile physiological saline solution at the rate 
of 10 l/g.rat/hour using a digital infusion 
pump. The infused solution contained 154mM 
Na+ and 154mM Cl-. A priming dose of inulin 
(16mg/kg) and para-Aminohippurate (PAH) 
(8mg/kg) was followed by an infusion of 
sterile NaCl solution containing inulin 
(36mg/ml) and PAH (5.8mg/ml) infused at a 
rate of 10lμ/g.rat/hr until steady state was 
reached (Fischer et al., 2000; Gabel et al., 
1996). Through a small lower abdominal 
incision, the urinary bladder was cannulated 
with a short self-retaining catheter (PP100 
polyethylene tubing). The urethra was legated 
to guard against spontaneous voiding. The 
abdominal incision was closed with a ligature, 
which also served the purpose of fixing the 
bladder catheter in place. The rectal 
temperature of the rat was maintained at 37.0 ± 
0.5oC throughout the experiment. 
After an equilibration period of 90 min, 
constancy in urine flow rate was tested. It was 
assumed that the rats have reached an 
equilibrium status when two 30 min. urine 
collection period yielded constant volume. 
Urine samples were thereafter collected in pre-
weighed vials for two 30 minutes periods. 
Arterial blood pressure was noted on the 
polygraph recording and heart rate was 
calculated against the timer recordings of the 
polygraph. 
Terminal blood samples were collected in 
heparinized bottles and blood plasma was 
immediately separated by centrifugation (3000 
r.p.m. for 10 mins). Plasma was stored in a 
deep freezer until required. Plasma electrolytes 
and plasma creatinine were measured within 
48 hours. At the end of the experiments, the 
body weight of the rats were compared with 
their initial weight and the heart and the 
kidneys (decapsulated in vivo) were excised 
and weighed immediately on a weighing 
balance after blotting with a commercial 
blotting paper. 
 
Analytical Methods  
Urine volume was determined 
gravimetrically in pre-weighed vials 
(Sardstadt) without correcting for specific 
gravity. Sodium and Potassium concentration 
in plasma and urine were determined using 
flame photometry and chloride was measured 
electrometrically. 
Creatinine was determined using the 
Jaffe's reaction according to Popper et al., 
(1937). The glomerular filtration rate was 




determined using inulin clearance according to 
Führ et al., (1955). In order to avoid 
overestimation of GFR that occurs when 
results are divided by body weight (Pollock et 
al., 1991), functional renal data in this study 
are given as absolute values. The renal plasma 
flow (RPF) was determined using the 
clearance of para-aminohippurate (PAH) 
according to Smith et al., (1945). A PAH 
extraction ratio of 0.9 was assumed.  
The American Physiological Society's 
guidelines for experimental animal research 
were adhered to in all of the experiments. 
 
Statistical Analysis 
Data analysis was done using a computer 
programme (SPSS 7.5 for windows). Results 
are given as means ± standard error of the 
means (SEM). The evaluation of data for 
statistical significance between control and 
experimental rats was done using unpaired 
Student-Newman-Keuls test. A value of 




Lead treated rats developed significant 
elevation of systolic (P<0.05), diastolic 
(P<0.05) and mean arterial blood pressures  
(P<0.01) (table 1). The body weights of the 
treated rats were not significantly different 
from controls (table 1). Hematocrit values 
were comparable in both groups of rats (table 
1). No significant difference in heart rate was 
observed under anesthesia in treated rats 
compared to controls (table 1). 
Combined kidney urine flow rate was not 
significantly different in the treated rats 
compared to controls (6.8±1.2 vs. 5.8±0.7 
μl/min). Similarly, renal blood flow (RBF) 
(3.99±0.28 ml/min vs. 4.19±0.63 ml/min) and 
glomerular filtration rate (GFR) (0.77±0.05 
ml/min vs. 0.88±0.06 ml/min) were not 
significantly different in treated rats compared 
to controls. No significant difference in serum 
creatinine concentration was observed 
(57.8±7.5 μmol/l vs. 49.0±2.7 μmol/l). Cardiac 
weight was not different in treated rats 
compared to controls (0.72±0.05g vs. 
0.73±0.08g). Similarly, kidney weights were 
comparable in the two groups (table 1).
 
 
Table 1: Summary of Renal function parameters and organ and body weights in lead treated (100ppm) 
and control rats.  
 
P-values are lead treated rats vs. untreated controls. SBP=systolic blood pressure; DBP=diasolic 
blood pressure; MAP=mean arterial blood pressure; RBF=renal blood flow; GFR=glomerular 
filtration rate; Rt=right; Lt=left 
 
 Lead Control P-Values 
Body Weight (g) 300.0±20.2 301.0±30.9 P=NS 
SBP (mmHg) 137.2±7.3 111.2±4.6 P<0.05 
DBP (mmHg) 103.0±3.0 88.0±3.6 P<0.05 
MAP (mmHg) 114.4±4.2 95.7±3.5 P<0.01 
Hematocrit  (%) 53.9±1.9 50.6±0.9 P=NS 
Urine flow rate V (μl/min) 6.8±1.2 5.8±0.7 P=NS 
RBF (ml/min) 3.99±0.28 4.19±0.63 P=NS 
GFR (ml/min) 0.77±0.05 0.88±0.06 P=NS 
Heart Rate (beats / min) 421.6±11.6 402.0±2.6 P=NS 
Heart weight (g) 0.72±0.05 0.73±0.08 P=NS 
Serum Creatinine ((μmol/l) 57.8±7.5 49.0±2.7 P=NS 
Plasma Sodium (mmol/l) 148.9±1.3 143.5±0.7 P<0.01 
Plasma Potassium (mmol/l) 4.57±0.27 3.66±0.18 P<0.05 
Plasma Chloride (mmol/l) 102.4±1.1 97.0±1.7 P<0.05 
Rt Kidney weight (g) 0.57±0.05 0.62±0.10 P=NS 
Lt Kidney weight (g) 0.57±0.06 0.63±0.08 P=NS 
 
Compared to control rats, lead treated rats had 
significant elevation of plasma sodium 
(148.9±1.3 mmol/l vs. 143.5±0.7 mmol/l; 
P<0.01), potassium (4.57±0.27 mmol/l vs. 
3.66±0.18 mmol/l; P<0.05) and chloride 
(102.4±1.1 vs. 97.0±1.7 mmol/l; P<0.05) 
concentrations (Table 1). Thus chronic 
exposure (3 months) to low levels of lead 










The main finding in this study is that 
chronic exposure to low-levels of lead resulted 
in electrolyte retention and elevation of blood 
pressure occurred at a stage when low level 
lead exposure did not alter renal function 
parameters appreciably.  There is 
overwhelming evidence in clinical studies to 
show that chronic, recurrent lead poisoning by 
causing increasing body lead load leads to 
impairment in renal function parameters 
(Restek-Samarzija et al., 1996). Clinical and 
experimental studies suggest an association 
between low-level lead exposure and 
hypertension (Fine et al., 1988; Vaziri et al., 
1999), which persists during ongoing exposure 
(Fine et al., 1988).  
Delayed adverse effect of occupational 
lead poisoning on kidney function and blood 
pressure are known to occur in humans 
(Restek-Samarzija et al., 1997). Among the 
possible mechanisms discussed in the 
pathogenesis of lead-induced hypertension is 
endothelial dysfunction, which occurs as a 
result of lead-induced increase in free radical 
production that scavenges endothelial nitric 
oxide (NO), leading to vascular hypertonus 
(Vaziri et al., 1999). Undoubtedly, the renal 
vascular endothelium is under strong influence 
of NO (Navar et al., 1996; Beierwaltes et al., 
1992). 
Our findings that low-level lead 
exposure cause an early increase in blood 
pressure is in agreement with those of others  
(Fine et al., 1988). Although limited exposure 
to lead can result in progressive renal 
insufficiency and hypertension (Aviv et al., 
1980), arterial hypertension is more strongly 
associated with renal dysfunction in lead 
workers (Pinto de Almeida et al., 1989). In the 
first 4 weeks, when chronic lead exposure did 
not alter renal functions or extracellular fluid 
volume, an associated increase in the activity 
of the renin-angiotensin system was reported 
in the dog; suggesting that hypertension may 
be a forerunner of renal impairment in low-
level lead intoxication (Fine et al., 1988).  In 
the present study, we found electrolyte 
retention after 3 months of exposure to low-
levels of lead in the rat. This suggests that fluid 
retention may be an additional mechanism 
responsible for lead-induced hypertension in 
the chronic stages of exposures to low levels of 
lead.   
Normally, acute oral protein load causes 
a transient hyperfiltration that can reveal a loss 
of glomerular permselectivity properties in the 
early stages of renal disease (Hotz et al., 
1996). However, test of acute protein loading 
was not found useful in revealing a silent 
glomerular filtration disturbance in lead 
exposed workers even though this procedure 
was useful in disclosing imminent renal 
tubular dysfunction in cadmium workers not 
yet showing increased microproteinuria under 
baseline conditions (Hotz et al., 1996). These 
evidences suggest that in the pathogenesis of 
low-level lead-induced renal damage, the 
kidney may very well be a victim of elevated 
blood pressure rather than the culprit. 
However, contradictory reports on the effect of 
lead on renal function parameters exist in the 
literature. Some studies reported a positive 
correlation between blood lead levels and GFR 
in rats; an observation that could be a 
reflection of the stimulatory effect of lead on 
renal hypertrophy and GFR (Khalil-Manesh et 
al., 1994).  However, these workers 
administered pharmacological doses of lead. In 
factory workers exposed to lead poisoning, a 
significantly reduced glomerular filtration rate, 
adjusted for age was reported (Restek-
Samarzija  and  Momcilovic , 1992). These 
observations were at variance with those from 
studies in which sustained low-dose of lead, as 
reported herein, were used. Prolonged low-
dose lead-treatment or acute high-dose lead-
treated that was discontinued after one month, 
failed to cause significant pathological changes 
in renal untrastructure in the rat (Khalil-
Manesh et al., 1992).  In addition, acute lead 
exposure had no effect on GFR or plasma 
aldosterone concentrations (Powers and 
Foulkes, 1985). Interestingly, prolonged 
exposure beyond 6 or 9 months not only 
resulted in severe tubulointerstitial disease but 
also caused a decreased GFR and an increase 
in serum creatinine and urea nitrogen 
compared to controls (Khalil-Manesh et al., 
1992; Khalil-Manesh et al., 1994). Thus as 
opposed to low-dose lead exposure, prolonged 
exposure to high dose of lead in rats may 
initially stimulate both renal cortical 
hypertrophy and an increase in GFR which 
later results in a fall in GFR as a result of 
predominant adverse effects of lead on the 
tubulointerstitium (Khalil-Manesh et al., 
1992). In addition, age at the time of exposure 
appears to be critical to the development of 
progressive renal damage (Tejani et al., 1986).  
Although nephrotoxicity is a common 
finding following exposure to lead, the dose-
response relationship in adults with 
occupational lead exposure and following 
chronic environmental pollution is not well 
established and information is lacking on the 
early nephrotoxic effects of lead in humans. 
By the time serum urea nitrogen and creatinine 
levels are elevated, renal damage may well be 




advanced (Hong et al., 1980). In addition, 
routine clinical laboratory tests are insensitive 
for the detection of early renal effects of lead 
poisoning. 
 
In conclusion, there is urgent need for 
further studies on the effect of environmental 
lead pollution on the kidneys and other body 
systems in our environment. It cannot be 
overemphasized that we may well be 
underestimating the effect of environmental 
lead pollution in our major cities in the 
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